tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ASND Stock Latest News

Specialised Therapeutics announces TGA approval of YORVIPATH
The FlySpecialised Therapeutics announces TGA approval of YORVIPATH
20h ago
ASND
Buy Rating for Ascendis Pharma: Yorvipath’s Strong Market Position and Growth Prospects
PremiumRatings
Buy Rating for Ascendis Pharma: Yorvipath’s Strong Market Position and Growth Prospects
2d ago
ASND
Ascendis Pharma: Favorable Market Position and Strong Prescription Growth Justify Buy Rating
PremiumRatings
Ascendis Pharma: Favorable Market Position and Strong Prescription Growth Justify Buy Rating
3d ago
ASND
Ascendis Pharma price target raised to $180 from $175 at Morgan Stanley
PremiumThe Fly
Ascendis Pharma price target raised to $180 from $175 at Morgan Stanley
3d ago
ASND
Ascendis Pharma’s Yorvipath: Impressive Launch and Strong Growth Potential Drive Buy Rating
PremiumRatings
Ascendis Pharma’s Yorvipath: Impressive Launch and Strong Growth Potential Drive Buy Rating
7d ago
ASND
Potential Share Dilution Looms for Ascendis Pharma: What Investors Need to Know
PremiumCompany AnnouncementsPotential Share Dilution Looms for Ascendis Pharma: What Investors Need to Know
7d ago
ASND
Ascendis Pharma A/S Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Ascendis Pharma A/S Earnings Call Highlights Growth and Challenges
7d ago
ASND
Ascendis Pharma price target raised to $162 from $153 at TD Cowen
Premium
The Fly
Ascendis Pharma price target raised to $162 from $153 at TD Cowen
8d ago
ASND
Ascendis Pharma price target lowered to $192 from $203 at BofA
PremiumThe Fly
Ascendis Pharma price target lowered to $192 from $203 at BofA
8d ago
ASND
Strong Buy Recommendation for Ascendis Pharma Driven by Yorvipath’s Successful US Launch and Future Growth Potential
PremiumRatings
Strong Buy Recommendation for Ascendis Pharma Driven by Yorvipath’s Successful US Launch and Future Growth Potential
8d ago
ASND
Ascendis Pharma: Promising Developments and Growth Prospects Drive Buy Rating
PremiumRatings
Ascendis Pharma: Promising Developments and Growth Prospects Drive Buy Rating
8d ago
ASND
Ascendis Pharma A/S Reports Strong 2024 Financial Growth
PremiumCompany Announcements
Ascendis Pharma A/S Reports Strong 2024 Financial Growth
8d ago
ASND
Closing Bell Movers: Cisco gains 7%, Robinhood up 15% on earnings
PremiumThe FlyClosing Bell Movers: Cisco gains 7%, Robinhood up 15% on earnings
8d ago
CW
APP
Ascendis Pharma: Strong Growth Prospects with New Product Launches and Strategic Milestones
Premium
Ratings
Ascendis Pharma: Strong Growth Prospects with New Product Launches and Strategic Milestones
8d ago
ASND
Ascendis Pharma Reports Strong 2024 Financial Results and Future Growth Plans
Premium
Company Announcements
Ascendis Pharma Reports Strong 2024 Financial Results and Future Growth Plans
9d ago
6K
ASND
Ascendis Pharma Launches $25 Million Share Repurchase Initiative
PremiumCompany Announcements
Ascendis Pharma Launches $25 Million Share Repurchase Initiative
9d ago
6K
ASND
Ascendis Pharma announces share repurchase program, settlement of certain RSUs
PremiumThe Fly
Ascendis Pharma announces share repurchase program, settlement of certain RSUs
9d ago
ASND
Ascendis Pharma reports Q4 EPS (EUR 0.64) vs (EUR 1.53) last year
PremiumThe Fly
Ascendis Pharma reports Q4 EPS (EUR 0.64) vs (EUR 1.53) last year
9d ago
ASND
Ascendis Pharma Issues New Employee Warrants
PremiumCompany Announcements
Ascendis Pharma Issues New Employee Warrants
9d ago
6K
ASND
Positive Outlook for Ascendis Pharma Boosted by Yorvipath Launch and Expert Involvement
PremiumRatingsPositive Outlook for Ascendis Pharma Boosted by Yorvipath Launch and Expert Involvement
10d ago
ASND
ASND Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ASND Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
ASND
Ascendis Pharma’s Yorvipath Launch and Market Positioning Bolster Buy Rating
Premium
Ratings
Ascendis Pharma’s Yorvipath Launch and Market Positioning Bolster Buy Rating
17d ago
ASND

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >